Share:
Peer-Reviewed Publication
Allergy2026;81(7):2478-2489.July 1, 2026Journal Article

Rapid Human Skin Barrier Disruption by Sodium Dodecyl Sulfate and Associated Molecular Mechanisms.

Manru Li1, Huseyn Babayev1, Paolo D'Avino1, Can Zeyneloğlu1, Ceren Bicer1, Duygu Yazici1, Yagiz Pat1, Per Svedenhag2, Nicolas Gaudenzio3,4, Cezmi A Akdis1,5, Yasutaka Mitamura1,6,7
1Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
2SciBase AB, Sundbyberg, Sweden.
3University of Toulouse, Inserm, CNRS, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Toulouse, France.
4Genoskin SAS, Toulouse, France.
5Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
6Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
7Department of Dermatology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.

Abstract

BACKGROUND: Epithelial barrier disruption is a hallmark of allergic skin diseases. Sodium dodecyl sulfate (SDS), a surfactant in household cleaning products, is known to impair the barrier. METHODS: We used a physiologically relevant ex vivo human skin combined with real-time electrical impedance spectroscopy (EIS) to monitor barrier integrity after SDS exposure. Multi-omics analyses, including R…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.